The stock of Icecure Medical Ltd (NASDAQ: ICCM) has decreased by -3.09 when compared to last closing price of 0.97. Despite this, the company has experienced a -8.74% fall in its stock price over the last five trading sessions. zacks.com reported 2024-06-04 that IceCure Medical (ICCM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
Is It Worth Investing in Icecure Medical Ltd (NASDAQ: ICCM) Right Now?
Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ICCM is 20.05M, and currently, short sellers hold a 1.21% ratio of that float. The average trading volume of ICCM on June 05, 2024 was 388.25K shares.
ICCM’s Market Performance
The stock of Icecure Medical Ltd (ICCM) has seen a -8.74% decrease in the past week, with a -21.01% drop in the past month, and a -24.19% fall in the past quarter. The volatility ratio for the week is 5.44%, and the volatility levels for the past 30 days are at 5.78% for ICCM. The simple moving average for the past 20 days is -13.44% for ICCM’s stock, with a -13.45% simple moving average for the past 200 days.
ICCM Trading at -19.88% from the 50-Day Moving Average
After a stumble in the market that brought ICCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.13% of loss for the given period.
Volatility was left at 5.78%, however, over the last 30 days, the volatility rate increased by 5.44%, as shares sank -26.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -25.41% lower at present.
During the last 5 trading sessions, ICCM fell by -13.10%, which changed the moving average for the period of 200-days by -11.38% in comparison to the 20-day moving average, which settled at $1.0703. In addition, Icecure Medical Ltd saw -12.15% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ICCM
Current profitability levels for the company are sitting at:
- -4.64 for the present operating margin
- 0.38 for the gross margin
The net margin for Icecure Medical Ltd stands at -4.4. The total capital return value is set at -1.3. Equity return is now at value -86.15, with -67.52 for asset returns.
Based on Icecure Medical Ltd (ICCM), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -23.08.
Currently, EBITDA for the company is -15.25 million with net debt to EBITDA at 0.68. When we switch over and look at the enterprise to sales, we see a ratio of 11.86. The receivables turnover for the company is 21.35for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.39.
Conclusion
To put it simply, Icecure Medical Ltd (ICCM) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
